Editor | Curator


Compass Pathways (CMPS) Reports 2Q and Business Highlights.

"Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. This is the largest trial ever conducted in...

Telehealth and Psychedelics: Contactless Health Screening from Ehave (EHVVF) and VastMindz.

Contactless Health Screening Ehave acquires License covering G-20 Countries for all Psychedelic use, AI-Powered Telehealth Technology To Capture Physiological Vitals From Vastmindz; Prepares To Run Testing On...

Wonderland: Miami

November 8-9, 2021 Click to visit site

Revive Therapeutics (RVVTF) Provides Update on Psychedelics Clinical Product Pipeline

Focusing on novel uses, production and delivery forms of psilocybin as a next generation solution for mental illness, substance abuse and neurological disordersAdvancing to FDA clinical studies for methamphetamine use disorder and...

Biomind Labs (BMND) Begins Trading on the NEO Exchange

LIVE QUOTE Toronto | July 28, 2021 – Today, NEO welcomes its newest corporate listing partner, Biomind Labs Inc. (“Biomind”), as it makes its public markets debut on the NEO Exchange. A...

Filament Health (FH.NE) is the First Public Company to be Issued a Patent for Extraction of Natural Psilocybin.

LIVE QUOTE Filament's patent describes the extraction of stable, standardized doses of psychoactive compounds at its Health...

Small Pharma (DMT) To Present At Canaccord Genuity’s Annual Growth Conference

Progress in the development of DMT-assisted therapy for the treatment of depression LONDON, Aug. 9, 2021 /CNW/ -- Small Pharma Inc. (TSXV: DMT) (the "Company" or "Small Pharma"), a...

Subscribe for Free!

EXCELLENT CHOICE, SIR! AND CHEERS TO YOU FOR SUBSCRIBING Subscribe For Your Free Copy to the 2024 Psychedelic Investor Guide

Editor | Curator